Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × sargramostim × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3 Thoracic 2 Gynecologic 2 Tumor-Agnostic 1 Sarcoma 1 Plasma cell 1 Other solid neoplasm 1 Myeloid 1 Lymphoid 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1 CNS 1 Breast 1

Conditions

Prostatic Neoplasms 20 Carcinoma, Renal Cell 10 Kidney Neoplasms 8 Lung Neoplasms 5 Colorectal Neoplasms 5 Colonic Neoplasms 5 Wilms Tumor 4 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Testicular Neoplasms 3 Rectal Neoplasms 3 Breast Neoplasms 3 Testicular Germ Cell Tumor 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Salivary Gland Neoplasms 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Melanoma 2 Liver Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Medullary 2

Interventions

pembrolizumab 24 Docetaxel 19 Gemcitabine 15 Paclitaxel 13 Prednisone 11 Nivolumab 11 pazopanib 10 Sorafenib 9 Radiotherapy 9 Therapeutics 7 Leuprolide 7 Ipilimumab 7 Cyclophosphamide 7 Cisplatin 7 Carboplatin 7 Blood Specimen Collection 7 Bevacizumab 7 avelumab 6 atezolizumab 6 Thalidomide 6 Sunitinib 6 Radiation 6 Interleukin-2 6 Cetuximab 6 Axitinib 6 Standard of Care 5 Radiosurgery 5 Denosumab 5 temsirolimus 4 padeliporfin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01784913 2024-12-16

UV1/hTERT2012P

Ultimovacs ASA

Phase 1/2 Completed

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡